KB-3061 (BPN-25203)

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 09/24/2019

Pipeline Type

New Drugs in Development

Phase Of Development

Preclinical

Sponsors and Collaborators

Knopp Biosciences

Mechanism of Action

Ion Channel

Mechanism Description

Potassium channel KV7.2/7.3 activators

Populations Tested In

N/A

Other Resources

Special FDA Designation

Nonprofit or Government Support

Government

Nonprofit or Government Support Description

NINDS - Blueprint neurotherapeutics grant

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
Epilepsy Precision Medicine Conference-September 2019

Location of Clinical Trials

N/A

Clinical Trial link

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.